PUBLISHER: IMARC | PRODUCT CODE: 1541034
PUBLISHER: IMARC | PRODUCT CODE: 1541034
Cytokine Market Report by Cytokine Type, Therapeutic Application, End User, and Region 2024-2032
The global cytokine market size reached US$ 89.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 163.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.76% during 2024-2032.
A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.
Cytokine Market Trends:
The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality. Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth. Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cytokine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cytokine type, therapeutic application and end user.
Breakup by Cytokine Type:
Tumor Necrosis Factor-TNF
Interleukins-Il
Interferons-IFN
Epidermal Growth Factor-EGF
Others
Breakup by Therapeutic Application:
Cancer
Asthma and Airway Inflammation
Arthritis
Others
Breakup by End User:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.
Key Questions Answered in This Report:
- How has the global cytokine market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global cytokine market?
- What are the key regional markets?
- What is the breakup of the market based on the cytokine type?
- What is the breakup of the market based on the therapeutic application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global cytokine market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cytokine Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Cytokine Type
- 6.1 Tumor Necrosis Factor-TNF
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Interleukins-Il
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Interferons-IFN
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Epidermal Growth Factor-EGF
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Therapeutic Application
- 7.1 Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Asthma and Airway Inflammation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Arthritis
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End User
- 8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Contract Research Organizations
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Academic and Research Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 AbbVie Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Abcam plc
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Amgen Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Applied Biological Materials Inc. (abm)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Bio-Techne Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 F. Hoffmann-La Roche AG
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 GenScript Biotech Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Randox Laboratories Ltd.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Thermo Fisher Scientific Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 UCB S.A.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.1 AbbVie Inc.
List of Figures
- Figure 1: Global: Cytokine Market: Major Drivers and Challenges
- Figure 2: Global: Cytokine Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Cytokine Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Cytokine Market: Breakup by Cytokine Type (in %), 2023
- Figure 5: Global: Cytokine Market: Breakup by Therapeutic Application (in %), 2023
- Figure 6: Global: Cytokine Market: Breakup by End User (in %), 2023
- Figure 7: Global: Cytokine Market: Breakup by Region (in %), 2023
- Figure 8: Global: Cytokine (Tumor Necrosis Factor-TNF) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Cytokine (Tumor Necrosis Factor-TNF) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Cytokine (Interleukins-Il) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Cytokine (Interleukins-Il) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Cytokine (Interferons-IFN) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Cytokine (Interferons-IFN) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Cytokine (Epidermal Growth Factor-EGF) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Cytokine (Epidermal Growth Factor-EGF) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Cytokine (Other Cytokine Types) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Cytokine (Other Cytokine Types) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Cytokine (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Cytokine (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Cytokine (Asthma and Airway Inflammation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Cytokine (Asthma and Airway Inflammation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Cytokine (Arthritis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Cytokine (Arthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Cytokine (Other Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Cytokine (Other Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Cytokine (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Cytokine (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Cytokine (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Cytokine (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: North America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: North America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: United States: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: United States: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Canada: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Canada: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Asia-Pacific: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Asia-Pacific: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: China: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: China: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Japan: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Japan: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: India: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: India: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: South Korea: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: South Korea: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Australia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Australia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Indonesia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Indonesia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Europe: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Europe: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Germany: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Germany: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: France: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: France: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: United Kingdom: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: United Kingdom: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Italy: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Italy: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Spain: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Spain: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Russia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Russia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Latin America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Latin America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Brazil: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Brazil: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Mexico: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Mexico: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Middle East and Africa: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Middle East and Africa: Cytokine Market: Breakup by Country (in %), 2023
- Figure 80: Middle East and Africa: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Global: Cytokine Industry: SWOT Analysis
- Figure 82: Global: Cytokine Industry: Value Chain Analysis
- Figure 83: Global: Cytokine Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Cytokine Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Cytokine Market Forecast: Breakup by Cytokine Type (in Million US$), 2024-2032
- Table 3: Global: Cytokine Market Forecast: Breakup by Therapeutic Application (in Million US$), 2024-2032
- Table 4: Global: Cytokine Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 5: Global: Cytokine Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Cytokine Market: Competitive Structure
- Table 7: Global: Cytokine Market: Key Players
